Blueshift Asset Management’s Cantel Medical Corporation CMD Stock Holding History

Blueshift Asset Management’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-17,976	Closed	-$1.44M	–	1272
2021 Q1	$1.44M	Buy	+17,976	New	+$1.4M	0.15%	189
2020 Q3	–	Sell	-9,866	Closed	-$436K	–	827
2020 Q2	$436K	Buy	+9,866	New	+$368K	0.07%	333
2020 Q1	–	Sell	-19,308	Closed	-$1.37M	–	798
2019 Q4	$1.37M	Buy	+19,308	New	+$1.4M	0.16%	200
2019 Q2	–	Sell	-8,131	Closed	-$544K	–	1043
2019 Q1	$544K	Sell	8,131 -246	-3%	-$18.6K	0.08%	377
2018 Q4	$624K	Buy	+8,377	New	+$692K	0.12%	288

Blueshift Asset Management's CMD Position: Q2 2021 in Review

Blueshift Asset Management sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 17,976 shares — an estimated $1.44M sold.

Blueshift Asset Management first reported a position in CMD in Q4 2018 and held it in 5 quarters. The position peaked at $1.44M in Q1 2021. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.

Blueshift Asset Management reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
Blueshift Asset Management sold 17,976 Cantel Medical Corporation shares in Q2 2021, an estimated $1.44M.
Blueshift Asset Management first reported a position in Cantel Medical Corporation in Q4 2018 and held it in 5 quarters.
Blueshift Asset Management's Cantel Medical Corporation position peaked at $1.44M in Q1 2021.
0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.

Based on Blueshift Asset Management's 13F filing for Q2 2021, filed 13 Aug 2021.